Protocol for Implementation of an AI-Integrated Patient Monitoring and Diagnostic Model in Smart Hospital Ecosystems: A Hybrid Type 2 Study

Protocol for Implementation of an AI-Integrated Patient Monitoring and Diagnostic Model in Smart Hospital Ecosystems: A Hybrid Type 2 Study | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Method Article Protocol for Implementation of an AI-Integrated Patient Monitoring and Diagnostic Model in Smart Hospital Ecosystems: A Hybrid Type 2 Study DUROJAIYE ILESANMI This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8565588/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Hospitals face mounting challenges in delivering proactive, patient-centered care amid resource constraints and rising clinical complexity. Conventional monitoring systems remain reactive and fragmented, leading to delayed interventions and increased adverse events. This paper presents a protocol for implementing an AI-integrated patient monitoring and diagnostic model designed for smart hospital ecosystems. The proposed architecture combines a clinician dashboard, patient-facing mobile application, and a cloud-based AI analytics core within an ethical governance framework. Using a Hybrid Type 2 implementation design, the system aims to unify real-time predictive monitoring, secure communication, and interoperability through HL7 FHIR standards. Anticipated outcomes include accelerated detection of clinical deterioration, reduced adverse event rates, enhanced patient engagement, and improved workflow efficiency. Beyond clinical benefits, the model offers scalable commercialization potential through modular architecture and cloud deployment, aligning with global digital health priorities and WHO strategies. This protocol lays the foundation for transforming hospital operations into intelligent, patient-centric ecosystems while ensuring compliance with HIPAA/GDPR and AI governance standards. Artificial Intelligence and Machine Learning Medical Informatics Information Retrieval and Management Artificial Intelligence Patient Monitoring Predictive Analytics Smart Hospitals Digital Health Interoperability AI Governance Figures Figure 1 Anticipated Outcomes and Preliminary Validation The proposed implementation is expected to deliver measurable improvements across clinical, operational, and patient-centered domains: 1)Clinical Impact: Rapid detection of deterioration and fewer adverse events through predictive alerts embedded in clinician dashboards. 2)Patient Engagement: Seamless continuity of care with high mobile app adherence, timely alert responsiveness even beyond discharge, and secure two-way communication between clinicians and patients . 3)Operational Efficiency: Streamlined workflows, on-the-go diagnostics, reduced hospital overcrowding, and optimized resource utilization powered by real-time monitoring and automated alerts. 4)Economic Advantage: The protocol clearly highlights scalable commercialization potential through modular AI architecture and cloud deployment, aligning with WHO digital health priorities. These anticipated outcomes are grounded in evidence from prior studies and the design principles outlined in this protocol, reinforcing feasibility for real-world deployment. I. INTRODUCTION Hospitals face increasing complexity and resource constraints, making proactive, patient-centered care essential. Conventional monitoring systems remain reactive and fragmented, contributing to delayed interventions and adverse events. This protocol builds on our earlier conceptual framework, which proposed an integrated architecture combining clinician dashboards, patient-facing mobile applications, and AI-driven analytics within an ethical governance structure. Evidence supports the need for such integration: AI-powered early warning systems reduce mortality and adverse events, mobile health interventions improve patient engagement, and governance frameworks ensure ethical deployment. Recent research underscores the transformative potential of AI in hospital ecosystems. Studies have demonstrated that multimodal deep learning approaches significantly improve early detection of clinical deterioration in ward patients [2]. Similarly, personalized mHealth interventions enhance patient engagement and adherence [3]. Governance frameworks remain critical for ethical AI deployment; bias monitoring and transparency audits are essential for maintaining trust and compliance in healthcare AI systems [4]. The present study adopts a Hybrid Type 2 design to evaluate both effectiveness and implementation strategies, extending monitoring beyond hospital walls to recently discharged patients. Objectives: 1)Primary: Evaluate the impact of the AI-integrated system on time to detect clinical deterioration and adverse event rates. 2)Secondary: Assess patient engagement, workflow efficiency, and governance compliance. 3)Exploratory: Examine the moderation effect of patient engagement on alert responsiveness and clinical outcomes. II. METHODS A. Study Design This study adopts a Hybrid Type 2 implementation research design, combining effectiveness evaluation with implementation strategies. A mixed-methods, pre–post intervention approach will be used to assess clinical outcomes, patient engagement, and governance compliance. B. Setting The study will be conducted in a hospital ecosystem equipped with electronic health record (EHR) infrastructure and discharge planning workflows. The intervention extends monitoring beyond hospital walls to patients recently discharged or scheduled for discharge. C. Participants 1) Inclusion Criteria: Adults aged ≥18 years Recently discharged or scheduled for discharge Existing treatment records in the hospital dashboard Access to a smartphone and internet connectivity 2) Exclusion Criteria: Cognitive impairment preventing app use Lack of internet access D. Sample Size Approximately 200 patients will be enrolled, based on feasibility and norms for Hybrid Type 2 designs. This sample size is considered sufficient to detect meaningful changes in engagement and clinical outcomes while maintaining operational practicality. Literature suggests that sample sizes in pilot or hybrid studies should prioritize practical feasibility while ensuring adequate precision for key outcomes [5;6]. Our choice aligns with ethical and methodological guidance for feasibility and implementation trials [7]. E. Recruitment Participants will be identified through hospital EHR and discharge planning teams. Contact will be made via phone or email. Hospital staff or family members may assist with mobile app installation if needed. F. Intervention Components The implementation consists of five integrated components; 1)Clinician Dashboard : Displays real-time clinical data, predictive alerts, and diagnostic insights. 2)Patient Mobile Application: Provides awareness alerts, secure messaging, teleconsultation, and wearable integration. 3)AI Analytics Core: Cloud-based predictive engine combining EHR and patient-generated data for risk scoring and personalized recommendations. 4)Integration Layer: Ensures interoperability using HL7 FHIR standards and secure APIs. 5)Governance & Communication Layer: Embeds bias monitoring, transparency checks, and secure clinician–patient interaction. Governance audits, including bias monitoring and transparency checks, will be conducted daily during the initial implementation phase and adjusted based on operational needs. The appointed hospital’s AI Governance Committee will oversee these audits and ensure compliance with ethical and regulatory standards. G. Participant Timeline The 12-month study will proceed in three phases: (1) preparatory activities, including IRB approval, consent finalization, and system setup; (2) a four-month intervention period during which participants engage with the mobile application and predictive alerts are generated; and (3) data analysis and dissemination of findings. Governance audits and technical monitoring will occur throughout the intervention to ensure compliance and system reliability. H. Outcome Measures 1)Primary Outcomes: a) Time to detect clinical deterioration (hours/days) b) Adverse event rate (per 100 patients) 2)Secondary Outcomes: a) Patient engagement (app usage frequency, alert responsiveness) b) Workflow efficiency (dashboard response time) 3)Exploratory: a) Moderation effect of engagement on alert responsiveness and clinical outcomes. I. Data Collection Data sources include hospital EHR, dashboard logs, mobile app usage data, and AI-generated outputs. Governance compliance will be monitored through audit logs and bias detection reports. J. Analysis Plan 1)Quantitative: Paired t-tests or mixed-effects models for pre–post comparisons; McNemar’s test for adverse event rates; moderation analysis for exploratory objectives. 2)Qualitative: Thematic analysis of interviews and focus groups to assess feasibility and acceptability. 3)Missing Data: Multiple imputation for missing engagement or clinical data if 20%. K. Risk Management and Contingency Measures Operational risks will be mitigated through targeted strategies: 1)Connectivity Failures: Implement SMS-based fallback alerts and offline data caching to maintain continuity during network outages. 2)Sensor Malfunction: Enable manual entry of vital signs and symptom reports within the mobile app to prevent data gaps. 3)Workflow Delays: Establish an escalation protocol that triggers automated notifications to care coordinators if dashboard alerts remain unacknowledged beyond predefined thresholds. These measures ensure resilience and minimize disruption to patient monitoring and clinical workflows. L. Ethical Considerations Prior to implementation, Institutional Review Board (IRB) approval will be obtained. All participants will provide informed consent using IRB-approved materials. Data will be managed in compliance with HIPAA and GDPR standards, with encryption applied both in transit and at rest. The consent form and participant information sheet, as approved by the ethics committee, will be included in the supplementary materials upon approval. III. TECHNICAL IMPLEMENTATION PLAN Building on the conceptual framework presented in our earlier work [1], this implementation adopts a modular architecture comprising a clinician dashboard, patient-facing mobile application, AI analytics core, interoperability layer, and governance mechanisms. Fig. 1 gives a detailed illustration of this modular architecture, which depicts the interaction between the clinician dashboard, patient mobile application, AI analytics core, integration layer, and governance mechanisms. Similar modular architectures have been successfully applied in healthcare AI implementations to enhance scalability and interoperability [2;3]. Governance layers, as emphasized by [4], are critical for ensuring fairness and transparency in AI-driven clinical workflows. These studies collectively support the design principles adopted in this protocol. The AI engine will integrate predictive models as designed and theoretically supported in the prior study [1], leveraging machine learning techniques such as gradient boosting and deep learning for early detection of clinical deterioration. Similar modular architectures have been successfully applied in healthcare AI implementations to enhance scalability and interoperability [2;3]. Governance layers, as emphasized by [4], are critical for ensuring fairness and transparency in AI-driven clinical workflows. Data exchange will be enabled through HL7 FHIR standards and secure APIs, while cloud deployment ensures scalability and compliance with HIPAA and GDPR. Explainability tools (e.g., SHAP, LIME) and bias monitoring will be embedded within the governance layer to maintain transparency and fairness. This section operationalizes the theoretical design into a real-world implementation strategy, emphasizing interoperability, security, and ethical compliance. The AI-integrated patient monitoring and diagnostic system will be developed and deployed through a structured, collaborative approach involving healthcare technology partners and cloud service providers. This plan prioritizes interoperability, scalability, security, and adherence to international standards and ethical governance frameworks. A. AI Model Development 1)Data Preparation: Historical electronic health record (EHR) data and patient-generated inputs (e.g., vitals, symptom reports) will be curated, anonymized, and standardized for model training. 2)Algorithm Selection: Advanced machine learning techniques (e.g., gradient boosting, deep learning) will be selected to enable predictive analytics for early detection of clinical deterioration. 3Training and Validation: Models will be trained on hospital datasets and validated using performance metrics such as AUC, sensitivity, and specificity to ensure robustness and fairness. B. Model Architecture and Validation The predictive engine will employ a hybrid architecture combining gradient boosting for structured EHR data and deep learning models (e.g., LSTM networks) for time-series patient-generated data. Training will utilize historical hospital datasets, anonymized and standardized for fairness. Validation will be conducted using stratified cross-validation, with performance metrics including AUC, sensitivity, specificity, and calibration plots. Explainability tools such as SHAP and LIME will be integrated to ensure transparency in model predictions. C. Integration into AI Analytics Core 1)Trained models will be embedded within the AI Analytics Core, serving as the central engine for predictive monitoring and diagnostic insights. 2)Secure APIs will enable real-time data ingestion from the Integration Layer, ensuring seamless connectivity. D. Cloud Deployment 1)The AI engine will be hosted on a secure, scalable cloud platform (e.g., Microsoft Azure, AWS, or hospital private cloud). 2)Containerization (Docker) and orchestration (Kubernetes) will support modular deployment and efficient resource management. 3)Edge computing will be incorporated for local processing of critical alerts, minimizing latency and enhancing responsiveness. E. Interoperability and Integration 1)HL7 FHIR standards will be applied to ensure seamless data exchange between hospital EHR systems, clinician dashboards, and patient-facing mobile applications. 2)Secure APIs will facilitate bidirectional communication between the cloud-based AI engine and user interfaces. F. Governance and Compliance 1)Continuous bias monitoring and fairness audits will be embedded within the Governance Layer. 2)Explainability tools (e.g., SHAP, LIME) will provide transparency in AI-driven decisions. 3)All data handling will comply with HIPAA and GDPR standards, with encryption applied for data in transit and at rest. G. Role of Technology Partners 1)AI development, cloud deployment, and system integration will be executed by partnering technology companies with expertise in healthcare AI solutions. 2)The research team will oversee governance, ethical compliance, and evaluation of system performance throughout the implementation process. IV. LOGIC MODEL OVERVIEW AND VISUAL ROADMAP The implementation roadmap follows a logic model structure (Inputs → Activities → Outputs → Outcomes → Impact). This model provides a high-level overview of resources, actions, and expected results. Table I summarizes the components, and Fig. 2 illustrates the visual roadmap. The detailed visual roadmap is provided in Supplementary File 1, while the logic model table is included in this section for quick reference. Table I: Logic Model for AI-Integrated Patient Monitoring and Diagnostic System Component Summary Inputs EHR & patient data; Modular system architecture; HL7 FHIR standards; Cloud infrastructure; Ethical approval; Stakeholder engagement Activities AI model development; Integration into Analytics Core; Cloud deployment; Mobile app development; Interoperability setup; Governance audits; Stakeholder training Outputs Designed AI Analytics Core; Purpose-built and AI-attached Clinician Dashboard; Connected Cloud-hosted Patient Mobile App; Secure Data Exchange Layer; Embedded AI Governance Platform Outcome Fully operational AI-integrated monitoring and diagnostic system, hosted on secure cloud, connected to hospital dashboard and patient mHealth app, integrated with predictive analytics engine, interoperability layer, and governance mechanisms Impact Digital health transformation; Scalable AI deployment; Policy influence; Alignment with WHO Digital Health Strategy & SDG 3 V. EVALUATION FRAMEWORK AND OUTCOME MEASURES The evaluation framework adopts a mixed-methods approach to assess both effectiveness and implementation outcomes in line with the study’s general objective of improving proactive patient monitoring and diagnostic accuracy. A. Primary Outcomes: 1)Time to detect clinical deterioration (measured in hours/days from onset to alert). 2)Adverse event rate (per 100 patients during the intervention period). B. Secondary Outcomes: 1)Patient engagement (frequency of app usage, responsiveness to alerts). 2)Workflow efficiency (dashboard response time, reduction in clinician workload). 3)Governance compliance (bias detection reports, transparency audits). C. Exploratory Outcomes: 1)Moderation effect of patient engagement on alert responsiveness and clinical outcomes. VI. DATA COLLECTION AND ANALYSIS PLAN A. Data Sources: 1)Clinical data from hospital EHR and dashboard logs. 2)Patient-generated data from mobile app (symptom reports, wearable metrics). 3)AI outputs (predictive alerts, risk scores). 4)Governance audit logs. B. Quantitative Analysis: 1)Pre–post comparisons using paired t-tests or mixed-effects models. 2)McNemar’s test for adverse event rates. 3)Moderation analysis for exploratory objectives. C. Qualitative Analysis: 1)Thematic analysis of interviews and focus groups to assess feasibility and acceptability. D. Missing Data: 1)Multiple imputation for missing engagement or clinical data (20%. VII. AI ETHICAL AND GOVERNANCE CONSIDERATIONS Institutional Review Board (IRB) approval will be obtained prior to implementation. Data handling will comply with HIPAA and GDPR standards, with encryption applied for data in transit and at rest. Governance mechanisms include continuous bias monitoring, fairness audits, and integration of explainability tools (e.g., SHAP, LIME) to ensure transparency and accountability. VIII. DISSEMINATION AND SCALE-UP PLAN Findings will be disseminated through peer-reviewed publications, conference presentations, and policy briefs. Anonymized datasets and analytic code will be deposited in an open-access repository (e.g., OSF) to promote transparency and reproducibility. Summary reports will be shared with participating clinicians and patients in accessible formats. A. Branding and Commercialization: The patient-facing mobile application and clinician dashboard will be branded in alignment with institutional and technology partner guidelines. Branding will emphasize usability, trust, and compliance with international standards to support adoption. B. Scale-Up Strategy: Following successful pilot implementation, the system will be optimized for scalability across diverse hospital ecosystems. This includes: 1)Modular architecture for easy integration with existing EHR systems. 2)Cloud-based deployment for multi-site expansion. 3)Licensing models and premium service options for sustainability. 4)Engagement with health authorities and technology partners for policy alignment and funding opportunities. IX. LIMITATIONS AND FUTURE SCOPE This protocol has several limitations that warrant consideration. First, it is designed for a single-site implementation, which may restrict generalizability across diverse hospital ecosystems with varying infrastructure, workflows, and governance practices. Multi-site trials will be essential to validate scalability and adaptability in different contexts. Second, the sample size of approximately 200 patients, while appropriate for a Hybrid Type 2 feasibility study, limits statistical power for subgroup analyses and long-term outcome evaluation. Future studies should incorporate larger cohorts to strengthen inferential validity. Third, reliance on hospital EHR data may introduce variability in data quality and completeness due to differences in documentation practices. Although the mobile application mitigates this by capturing real-time patient-reported data, historical inconsistencies in EHR records could still influence predictive accuracy. Advanced data harmonization techniques and integration with IoT-enabled devices may further reduce this risk. Fourth, the AI models employed in this protocol are trained on site-specific datasets, which may limit external validity. Incorporating federated learning or multi-institutional datasets in future iterations could enhance model robustness and fairness across diverse populations. Looking ahead, future research should explore multi-site deployments, integration with wearable IoT sensors for richer data streams, and advanced explainability techniques to improve clinician trust and decision-making. Additionally, longitudinal studies assessing cost-effectiveness, policy implications, and patient-reported outcomes will be critical for large-scale adoption and alignment with global digital health strategies. These mitigation strategies and future directions underscore the protocol’s adaptability and its potential to evolve into a scalable, multi-site solution for AI-driven patient monitoring. X. ESTIMATED BUDGET Estimated budget details are provided in Supplementary File 2 to maintain clarity and conciseness in the main text. Declarations Acknowledgments I acknowledge God for inspiration throughout this work. Conflict of Interest: The author declares no conflicts of interest related to this study. Funding: No external funding has been secured for this research yet. Data Availability: This study is conceptual and does not involve primary data; therefore, no datasets were generated or analyzed. Ethical Approval: Not applicable as this study did not involve human participants or patient data. Consent for Publication: Not applicable as this study is a single-author work. Plagiarism and Originality Statement: The manuscript does not contain any material that constitutes plagiarism. AI tools were used only for minor language refinement (e.g., correcting tenses) after the paper was written, without altering originality or intellectual content. References Ilesanmi D (2025) AI-integrated patient monitoring and diagnostic model for smart hospital ecosystems. J Healthc Inf Res under Rev. 10.17605/OSF.IO/UAQWG Kotula CA, Martin J, Carey KA, Edelson DP, Dligach D, Mayampurath A, Afshar M, Churpek MM (2025) Comparison of multimodal deep learning approaches for predicting clinical deterioration in ward patients: Observational cohort study. J Med Internet Res 27:e75340. 10.2196/75340 Baig MM et al (2024) Personalized mHealth interventions using AI: A systematic review. Appl Sci 14(23):10899. 10.3390/app142310899 Ghosh R et al (2025) Ethical and governance frameworks for AI in healthcare: A systematic review. AI Soc. 10.1007/s00146-025-02312-y Ying K, Whitehead AL, Julious SA (2025) Determining sample size for pilot trials: A tutorial. BMJ Open 15(3):e078123. 10.1136/bmjopen-2025-078123 Montgomery AA, Peters TJ, Little P (2025) Design, analysis and presentation of pilot studies: Recommendations for good practice. J Clin Epidemiol 68(2):139–147. 10.1016/j.jclinepi.2025.01.001 Lakens D (2022) Sample size justification. Collabra: Psychol 8(1):33267. 10.1525/collabra.33267 Additional Declarations The authors declare no competing interests. Supplementary Files Figure2Supplementaryfile1.pdf Fig. 2: Visual Roadmap for AI-Integrated Patient Monitoring and Diagnostic System Table2Suppliemntaryfile2.pdf Table II: Budget Estimate for AI-Integrated Patient Monitoring and Diagnostic Model Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8565588","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Method Article","associatedPublications":[],"authors":[{"id":572373098,"identity":"eb61baa5-afa2-46e3-83ec-8817c17f2a4e","order_by":0,"name":"DUROJAIYE ILESANMI","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA+0lEQVRIiWNgGAWjYBACNgYGAzAFZDA++FABZDMzNxCthdlwxhmQFkb8WhggWiDapXnbQDQBLXwMzNukKyr45Pkkkg8b8M6rjeZvB2r5UbENj8PYyiTPnGEzbJNIS3wgue147ozDjA2MPWdu49HCYybZ2MbG2CaRY2xguO1YbgNQCzNjG2Et9m0S+d8kEuccy51PrJZEoC1sEgcbanI3ENTCzFZs2XCGLbmN55mxYcOxA7kbgVoO4vOLfHvzxpsNFcds57cnP3z8p6Yud975wwcf/KjArYWBGUweY2AQSAAxDoO5B3Crh4MaBgZ+sLo6IhSPglEwCkbBSAMAPB9UUtk96sgAAAAASUVORK5CYII=","orcid":"https://orcid.org/0000-0001-7223-3020","institution":"Universiti Putra Malaysia","correspondingAuthor":true,"prefix":"","firstName":"DUROJAIYE","middleName":"","lastName":"ILESANMI","suffix":""}],"badges":[],"createdAt":"2026-01-10 04:42:28","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-8565588/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8565588/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":100367606,"identity":"a387d103-19e2-42c3-8f65-0cbd6f2dc526","added_by":"auto","created_at":"2026-01-16 07:57:09","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":66275,"visible":true,"origin":"","legend":"","description":"","filename":"ProtocolforImplementationofanAIIntegratedPatientMonitoringandDiagnosticModelinSmartHospitalEcosystems.docx","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/10ac7a74f70bc2c33dd9b792.docx"},{"id":100367209,"identity":"3e2cf580-de68-4d16-b7ac-100904bdaa25","added_by":"auto","created_at":"2026-01-16 07:56:50","extension":"json","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":342,"visible":true,"origin":"","legend":"","description":"","filename":"rs8565588.json","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/c2e9c520187bfdd1edfbfc94.json"},{"id":100133668,"identity":"795d1cdf-9179-4eb3-822a-ca0de01686e5","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"xml","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":47559,"visible":true,"origin":"","legend":"","description":"","filename":"rs85655880enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/c5c977931751a5a6a7ed298e.xml"},{"id":100133678,"identity":"73494859-991b-497f-a006-5beca689615d","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"eps","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":369,"visible":true,"origin":"","legend":"","description":"","filename":"drawingimage1.eps","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/1cc7220ee62943ed8d2fddb4.eps"},{"id":100367962,"identity":"43d1fe7c-82b2-4554-b2c5-28db811b5bb3","added_by":"auto","created_at":"2026-01-16 07:57:29","extension":"eps","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":546,"visible":true,"origin":"","legend":"","description":"","filename":"drawingimage2.eps","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/f6423fed77341dca71ffe009.eps"},{"id":100367985,"identity":"52ba4f70-110c-404e-9016-e3039fdcaa98","added_by":"auto","created_at":"2026-01-16 07:57:30","extension":"eps","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":751,"visible":true,"origin":"","legend":"","description":"","filename":"drawingimage3.eps","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/5c99678710b301851283bd42.eps"},{"id":100367076,"identity":"db3e8732-3276-4339-9377-ccf63a86e579","added_by":"auto","created_at":"2026-01-16 07:56:45","extension":"eps","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":512,"visible":true,"origin":"","legend":"","description":"","filename":"drawingimage4.eps","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/18daf9fd7c9439fd03d2d423.eps"},{"id":100366672,"identity":"3af0f160-c6d2-4bc2-a6e2-0d1f748be350","added_by":"auto","created_at":"2026-01-16 07:56:28","extension":"eps","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":253147,"visible":true,"origin":"","legend":"","description":"","filename":"drawingimage5.eps","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/78771c9851018032ba2e4845.eps"},{"id":100366501,"identity":"039c04ed-414a-417a-a0b4-5787d7aee30f","added_by":"auto","created_at":"2026-01-16 07:56:19","extension":"eps","order_by":8,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":135365,"visible":true,"origin":"","legend":"","description":"","filename":"drawingimage6.eps","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/a0af31e816515415be4671f4.eps"},{"id":100368106,"identity":"f5cac891-042c-4516-80de-8fc7d0930d34","added_by":"auto","created_at":"2026-01-16 07:57:36","extension":"eps","order_by":9,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":512,"visible":true,"origin":"","legend":"","description":"","filename":"drawingimage4.eps","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/7e2194e95a26bd0fd70b6daa.eps"},{"id":100367663,"identity":"c8b79191-31bc-46c6-95d5-a94226fe84f5","added_by":"auto","created_at":"2026-01-16 07:57:13","extension":"eps","order_by":10,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":145723,"visible":true,"origin":"","legend":"","description":"","filename":"drawingimage8.eps","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/d1e89e46823b5fbb15cd6d31.eps"},{"id":100133676,"identity":"1b75efa1-15f3-4451-970d-c094a58f0a0d","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"jpeg","order_by":12,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":180887,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage2.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/5cf4036e08390f78ac51c55e.jpeg"},{"id":100133673,"identity":"60d2797a-f3a7-4796-9146-70dc68cbe3b6","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"jpeg","order_by":13,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":24623,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage3.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/af5023f96d7d208f257ca6a4.jpeg"},{"id":100366678,"identity":"129a468b-3141-434e-bb4f-bcdac75552b7","added_by":"auto","created_at":"2026-01-16 07:56:28","extension":"jpeg","order_by":14,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":1074,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage4.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/0c97a8aafeb192ca3e779834.jpeg"},{"id":100133682,"identity":"e6944f3a-7ca4-4dff-b593-02859099e452","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"png","order_by":15,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":935,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage4.png","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/207abe58a922a9f9a8e334e2.png"},{"id":100133679,"identity":"f1b7de52-1aad-4aa8-9424-b95c0eb8c675","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"xml","order_by":16,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":46149,"visible":true,"origin":"","legend":"","description":"","filename":"rs85655880structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/0143f61f8c842bc86de671dd.xml"},{"id":100368020,"identity":"261c5549-3786-4855-8ee4-f3a9655502d6","added_by":"auto","created_at":"2026-01-16 07:57:31","extension":"html","order_by":17,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":58067,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/7bf39417342c849e16563e45.html"},{"id":100133664,"identity":"7d9780fa-1d6d-48af-82c8-e7386ee4a1fb","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":107937,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eConceptual architecture of the AI-integrated patient monitoring and diagnostic model.\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/c35f0d5eec0d2e72c338a2a6.jpg"},{"id":100405643,"identity":"7486b3c3-5c69-4f0c-b484-2013e2321ee8","added_by":"auto","created_at":"2026-01-16 12:09:36","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":592221,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/a0b3c455-45ca-4532-a504-65adfec88d29.pdf"},{"id":100133665,"identity":"d8dfe98a-cedc-416c-9736-2f68f35b7134","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":184291,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eFig. 2: Visual Roadmap for AI-Integrated Patient Monitoring and Diagnostic System\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"Figure2Supplementaryfile1.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/cf379cbe216001d767f9ab06.pdf"},{"id":100133670,"identity":"00dbaadc-21ab-4eee-b0a1-887c083dbf49","added_by":"auto","created_at":"2026-01-13 10:28:26","extension":"pdf","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":175480,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eTable II: Budget Estimate for AI-Integrated Patient Monitoring and Diagnostic Model\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"Table2Suppliemntaryfile2.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8565588/v1/13f93e5bfe492f7440054b12.pdf"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"\u003cp\u003e\u003cstrong\u003eProtocol for Implementation of an AI-Integrated Patient Monitoring and Diagnostic Model in Smart Hospital Ecosystems: A Hybrid Type 2 Study\u003c/strong\u003e\u003c/p\u003e","fulltext":[{"header":"Anticipated Outcomes and Preliminary Validation","content":"\u003cp\u003eThe proposed implementation is expected to deliver measurable improvements across clinical, operational, and patient-centered domains:\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e1)Clinical Impact:\u003c/em\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003eRapid detection of deterioration and fewer adverse events through predictive alerts embedded in clinician dashboards.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e2)Patient Engagement:\u003c/em\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003eSeamless continuity of care with high mobile app adherence, timely alert responsiveness even beyond discharge, and secure two-way communication between clinicians and patients\u003cstrong\u003e.\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e3)Operational Efficiency:\u003c/em\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003eStreamlined workflows, on-the-go diagnostics, reduced hospital overcrowding, and optimized resource utilization powered by real-time monitoring and automated alerts.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e4)Economic Advantage:\u003c/em\u003e The protocol clearly highlights scalable commercialization potential through modular AI architecture and cloud deployment, aligning with WHO digital health priorities.\u003c/p\u003e\n\u003cp\u003eThese anticipated outcomes are grounded in evidence from prior studies and the design principles outlined in this protocol, reinforcing feasibility for real-world deployment.\u003c/p\u003e"},{"header":"I. INTRODUCTION","content":"\u003cp\u003eHospitals face increasing complexity and resource constraints, making proactive, patient-centered care essential. Conventional monitoring systems remain reactive and fragmented, contributing to delayed interventions and adverse events. This protocol builds on our earlier conceptual framework, which proposed an integrated architecture combining clinician dashboards, patient-facing mobile applications, and AI-driven analytics within an ethical governance structure. Evidence supports the need for such integration: AI-powered early warning systems reduce mortality and adverse events, mobile health interventions improve patient engagement, and governance frameworks ensure ethical deployment.\u003c/p\u003e\n\u003cp\u003eRecent research underscores the transformative potential of AI in hospital ecosystems. Studies have demonstrated that multimodal deep learning approaches significantly improve early detection of clinical deterioration in ward patients [2]. Similarly, personalized mHealth interventions enhance patient engagement and adherence [3]. Governance frameworks remain critical for ethical AI deployment; bias monitoring and transparency audits are essential for maintaining trust and compliance in healthcare AI systems [4].\u003c/p\u003e\n\u003cp\u003eThe present study adopts a Hybrid Type 2 design to evaluate both effectiveness and implementation strategies, extending monitoring beyond hospital walls to recently discharged patients.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eObjectives:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e1)Primary:\u003c/em\u003e Evaluate the impact of the AI-integrated system on time to detect clinical deterioration and adverse event rates.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e2)Secondary:\u003c/em\u003e Assess patient engagement, workflow efficiency, and governance compliance.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e3)Exploratory:\u003c/em\u003e Examine the moderation effect of patient engagement on alert responsiveness and clinical outcomes.\u003c/p\u003e"},{"header":"II. METHODS","content":"\u003cp\u003e\u003cem\u003eA. Study Design\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThis study adopts a Hybrid Type 2 implementation research design, combining effectiveness evaluation with implementation strategies. A mixed-methods, pre–post intervention approach will be used to assess clinical outcomes, patient engagement, and governance compliance.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eB. Setting\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe study will be conducted in a hospital ecosystem equipped with electronic health record (EHR) infrastructure and discharge planning workflows. The intervention extends monitoring beyond hospital walls to patients recently discharged or scheduled for discharge.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eC. Participants\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e1) Inclusion Criteria:\u003c/em\u003e\u003c/p\u003e\n\u003col\u003e\n \u003cli\u003eAdults aged ≥18 years\u003c/li\u003e\n \u003cli\u003eRecently discharged or scheduled for discharge\u003c/li\u003e\n \u003cli\u003eExisting treatment records in the hospital dashboard\u003c/li\u003e\n \u003cli\u003eAccess to a smartphone and internet connectivity\u003c/li\u003e\n\u003c/ol\u003e\n\u003cp\u003e\u003cem\u003e2) Exclusion Criteria:\u003c/em\u003e\u003c/p\u003e\n\u003col\u003e\n \u003cli\u003eCognitive impairment preventing app use\u003c/li\u003e\n \u003cli\u003eLack of internet access\u003c/li\u003e\n\u003c/ol\u003e\n\u003cp\u003e\u003cem\u003eD. Sample Size\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eApproximately \u003cstrong\u003e200 patients\u003c/strong\u003e will be enrolled, based on feasibility and norms for Hybrid Type 2 designs. This sample size is considered sufficient to detect meaningful changes in engagement and clinical outcomes while maintaining operational practicality. Literature suggests that sample sizes in pilot or hybrid studies should prioritize practical feasibility while ensuring adequate precision for key outcomes [5;6]. Our choice aligns with ethical and methodological guidance for feasibility and implementation trials [7].\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eE. Recruitment\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eParticipants will be identified through hospital EHR and discharge planning teams. Contact will be made via phone or email. Hospital staff or family members may assist with mobile app installation if needed.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eF. Intervention Components\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe implementation consists of five integrated components;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e1)Clinician Dashboard\u003c/em\u003e\u003cstrong\u003e:\u003c/strong\u003e Displays real-time clinical data, predictive alerts, and diagnostic insights.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e2)Patient Mobile Application:\u003c/em\u003e Provides awareness alerts, secure messaging, teleconsultation, and wearable integration.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e3)AI Analytics Core:\u003c/em\u003e Cloud-based predictive engine combining EHR and patient-generated data for risk scoring and personalized recommendations.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e4)Integration Layer:\u003c/em\u003e Ensures interoperability using HL7 FHIR standards and secure APIs.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e5)Governance \u0026amp; Communication Layer:\u003c/em\u003e Embeds bias monitoring, transparency checks, and secure clinician–patient interaction. Governance audits, including bias monitoring and transparency checks, will be conducted daily during the initial implementation phase and adjusted based on operational needs. The appointed hospital’s AI Governance Committee will oversee these audits and ensure compliance with ethical and regulatory standards.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eG. Participant Timeline\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe 12-month study will proceed in three phases: (1) preparatory activities, including IRB approval, consent finalization, and system setup; (2) a four-month intervention period during which participants engage with the mobile application and predictive alerts are generated; and (3) data analysis and dissemination of findings. Governance audits and technical monitoring will occur throughout the intervention to ensure compliance and system reliability.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eH. Outcome Measures\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e1)Primary Outcomes:\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003ea) Time to detect clinical deterioration (hours/days)\u003c/p\u003e\n\u003cp\u003eb) Adverse event rate (per 100 patients)\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e2)Secondary Outcomes:\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003ea) Patient engagement (app usage frequency, alert responsiveness)\u003c/p\u003e\n\u003cp\u003eb) Workflow efficiency (dashboard response time)\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e3)Exploratory:\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003ea) Moderation effect of engagement on alert responsiveness and clinical outcomes.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eI. Data Collection\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eData sources include hospital EHR, dashboard logs, mobile app usage data, and AI-generated outputs. Governance compliance will be monitored through audit logs and bias detection reports.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eJ. Analysis Plan\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e1)Quantitative:\u0026nbsp;\u003c/em\u003ePaired t-tests or mixed-effects models for pre–post comparisons; McNemar’s test for adverse event rates; moderation analysis for exploratory objectives.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e2)Qualitative:\u003c/em\u003e Thematic analysis of interviews and focus groups to assess feasibility and acceptability.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e3)Missing Data:\u003c/em\u003e Multiple imputation for missing engagement or clinical data if \u0026lt;20%; exclusion if \u0026gt;20%.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eK. Risk Management and Contingency Measures\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eOperational risks will be mitigated through targeted strategies:\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e1)Connectivity Failures:\u003c/em\u003e Implement SMS-based fallback alerts and offline data caching to maintain continuity during network outages.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e2)Sensor Malfunction:\u003c/em\u003e Enable manual entry of vital signs and symptom reports within the mobile app to prevent data gaps.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e3)Workflow Delays:\u003c/em\u003e Establish an escalation protocol that triggers automated notifications to care coordinators if dashboard alerts remain unacknowledged beyond predefined thresholds.\u003c/p\u003e\n\u003cp\u003eThese measures ensure resilience and minimize disruption to patient monitoring and clinical workflows.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eL. Ethical Considerations\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003ePrior to implementation, Institutional Review Board (IRB) approval will be obtained. All participants will provide informed consent using IRB-approved materials. Data will be managed in compliance with HIPAA and GDPR standards, with encryption applied both in transit and at rest. The consent form and participant information sheet, as approved by the ethics committee, will be included in the supplementary materials upon approval.\u003c/p\u003e"},{"header":"III. TECHNICAL IMPLEMENTATION PLAN","content":"\u003cp\u003eBuilding on the conceptual framework presented in our earlier work [1], this implementation adopts a modular architecture comprising a clinician dashboard, patient-facing mobile application, AI analytics core, interoperability layer, and governance mechanisms. Fig. 1 gives a detailed illustration of this modular architecture, which depicts the interaction between the clinician dashboard, patient mobile application, AI analytics core, integration layer, and governance mechanisms.\u003c/p\u003e\n\u003cp\u003eSimilar modular architectures have been successfully applied in healthcare AI implementations to enhance scalability and interoperability [2;3]. Governance layers, as emphasized by [4], are critical for ensuring fairness and transparency in AI-driven clinical workflows. These studies collectively support the design principles adopted in this protocol.\u003c/p\u003e\n\u003cp\u003eThe AI engine will integrate predictive models as designed and theoretically supported in the prior study [1], leveraging machine learning techniques such as gradient boosting and deep learning for early detection of clinical deterioration. Similar modular architectures have been successfully applied in healthcare AI implementations to enhance scalability and interoperability [2;3]. Governance layers, as emphasized by [4], are critical for ensuring fairness and transparency in AI-driven clinical workflows.\u003c/p\u003e\n\u003cp\u003eData exchange will be enabled through HL7 FHIR standards and secure APIs, while cloud deployment ensures scalability and compliance with HIPAA and GDPR. Explainability tools (e.g., SHAP, LIME) and bias monitoring will be embedded within the governance layer to maintain transparency and fairness. This section operationalizes the theoretical design into a real-world implementation strategy, emphasizing interoperability, security, and ethical compliance.\u003c/p\u003e\n\u003cp\u003eThe AI-integrated patient monitoring and diagnostic system will be developed and deployed through a structured, collaborative approach involving healthcare technology partners and cloud service providers. This plan prioritizes interoperability, scalability, security, and adherence to international standards and ethical governance frameworks.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eA. AI Model Development\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e1)Data Preparation:\u003c/em\u003e Historical electronic health record (EHR) data and patient-generated inputs (e.g., vitals, symptom reports) will be curated, anonymized, and standardized for model training.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e2)Algorithm Selection:\u003c/em\u003e Advanced machine learning techniques (e.g., gradient boosting, deep learning) will be selected to enable predictive analytics for early detection of clinical deterioration.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e3Training and Validation:\u003c/em\u003e Models will be trained on hospital datasets and validated using performance metrics such as AUC, sensitivity, and specificity to ensure robustness and fairness.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eB. Model Architecture and Validation\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe predictive engine will employ a hybrid architecture combining gradient boosting for structured EHR data and deep learning models (e.g., LSTM networks) for time-series patient-generated data. Training will utilize historical hospital datasets, anonymized and standardized for fairness. Validation will be conducted using stratified cross-validation, with performance metrics including AUC, sensitivity, specificity, and calibration plots. Explainability tools such as SHAP and LIME will be integrated to ensure transparency in model predictions.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eC. Integration into AI Analytics Core\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Trained models will be embedded within the AI Analytics Core, serving as the central engine for predictive monitoring and diagnostic insights.\u003c/p\u003e\n\u003cp\u003e2)Secure APIs will enable real-time data ingestion from the Integration Layer, ensuring seamless connectivity.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eD. Cloud Deployment\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)The AI engine will be hosted on a secure, scalable cloud platform (e.g., Microsoft Azure, AWS, or hospital private cloud).\u003c/p\u003e\n\u003cp\u003e2)Containerization (Docker) and orchestration (Kubernetes) will support modular deployment and efficient resource management.\u003c/p\u003e\n\u003cp\u003e3)Edge computing will be incorporated for local processing of critical alerts, minimizing latency and enhancing responsiveness.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eE. Interoperability and Integration\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)HL7 FHIR standards will be applied to ensure seamless data exchange between hospital EHR systems, clinician dashboards, and patient-facing mobile applications.\u003c/p\u003e\n\u003cp\u003e2)Secure APIs will facilitate bidirectional communication between the cloud-based AI engine and user interfaces.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eF. Governance and Compliance\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Continuous bias monitoring and fairness audits will be embedded within the Governance Layer.\u003c/p\u003e\n\u003cp\u003e2)Explainability tools (e.g., SHAP, LIME) will provide transparency in AI-driven decisions.\u003c/p\u003e\n\u003cp\u003e3)All data handling will comply with HIPAA and GDPR standards, with encryption applied for data in transit and at rest.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eG. Role of Technology Partners\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)AI development, cloud deployment, and system integration will be executed by partnering technology companies with expertise in healthcare AI solutions.\u003c/p\u003e\n\u003cp\u003e2)The research team will oversee governance, ethical compliance, and evaluation of system performance throughout the implementation process.\u003c/p\u003e"},{"header":"IV. LOGIC MODEL OVERVIEW AND VISUAL ROADMAP","content":"\u003cp\u003eThe implementation roadmap follows a logic model structure (Inputs → Activities → Outputs → Outcomes → Impact). This model provides a high-level overview of resources, actions, and expected results. Table I summarizes the components, and Fig. 2 illustrates the visual roadmap. The detailed visual roadmap is provided in Supplementary File 1, while the logic model table is included in this section for quick reference.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable I: Logic Model for AI-Integrated Patient Monitoring and Diagnostic System\u003c/strong\u003e\u003c/p\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eComponent\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eSummary\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eInputs\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eEHR \u0026amp; patient data; Modular system architecture; HL7 FHIR standards; Cloud infrastructure; Ethical approval; Stakeholder engagement\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eActivities\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eAI model development; Integration into Analytics Core; Cloud deployment; Mobile app development; Interoperability setup; Governance audits; Stakeholder training\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eOutputs\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eDesigned AI Analytics Core; Purpose-built and AI-attached Clinician Dashboard; Connected Cloud-hosted Patient Mobile App; Secure Data Exchange Layer; Embedded AI Governance Platform\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eOutcome\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eFully operational AI-integrated monitoring and diagnostic system, hosted on secure cloud, connected to hospital dashboard and patient mHealth app, integrated with predictive analytics engine, interoperability layer, and governance mechanisms\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eImpact\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eDigital health transformation; Scalable AI deployment; Policy influence; Alignment with WHO Digital Health Strategy \u0026amp; SDG 3\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e"},{"header":"V. EVALUATION FRAMEWORK AND OUTCOME MEASURES","content":"\u003cp\u003eThe evaluation framework adopts a mixed-methods approach to assess both effectiveness and implementation outcomes in line with the study\u0026rsquo;s general objective of improving proactive patient monitoring and diagnostic accuracy.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eA. Primary Outcomes:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Time to detect clinical deterioration (measured in hours/days from onset to alert).\u003c/p\u003e\n\u003cp\u003e2)Adverse event rate (per 100 patients during the intervention period).\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eB. Secondary Outcomes:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Patient engagement (frequency of app usage, responsiveness to alerts).\u003c/p\u003e\n\u003cp\u003e2)Workflow efficiency (dashboard response time, reduction in clinician workload).\u003c/p\u003e\n\u003cp\u003e3)Governance compliance (bias detection reports, transparency audits).\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eC. Exploratory Outcomes:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Moderation effect of patient engagement on alert responsiveness and clinical outcomes.\u003c/p\u003e"},{"header":"VI. DATA COLLECTION AND ANALYSIS PLAN","content":"\u003cp\u003e\u003cem\u003eA. Data Sources:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Clinical data from hospital EHR and dashboard logs.\u003c/p\u003e\n\u003cp\u003e2)Patient-generated data from mobile app (symptom reports, wearable metrics).\u003c/p\u003e\n\u003cp\u003e3)AI outputs (predictive alerts, risk scores).\u003c/p\u003e\n\u003cp\u003e4)Governance audit logs.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eB. Quantitative Analysis:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Pre\u0026ndash;post comparisons using paired t-tests or mixed-effects models.\u003c/p\u003e\n\u003cp\u003e2)McNemar\u0026rsquo;s test for adverse event rates.\u003c/p\u003e\n\u003cp\u003e3)Moderation analysis for exploratory objectives.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eC. Qualitative Analysis:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Thematic analysis of interviews and focus groups to assess feasibility and acceptability.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eD. Missing Data:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e1)Multiple imputation for missing engagement or clinical data (\u0026lt;20%).\u003c/p\u003e\n\u003cp\u003e2)Exclusion if \u0026gt;20%.\u003c/p\u003e"},{"header":"VII. AI ETHICAL AND GOVERNANCE CONSIDERATIONS","content":"\u003cp\u003eInstitutional Review Board (IRB) approval will be obtained prior to implementation. Data handling will comply with HIPAA and GDPR standards, with encryption applied for data in transit and at rest. Governance mechanisms include continuous bias monitoring, fairness audits, and integration of explainability tools (e.g., SHAP, LIME) to ensure transparency and accountability.\u003c/p\u003e"},{"header":"VIII. DISSEMINATION AND SCALE-UP PLAN","content":"\u003cp\u003eFindings will be disseminated through peer-reviewed publications, conference presentations, and policy briefs. Anonymized datasets and analytic code will be deposited in an open-access repository (e.g., OSF) to promote transparency and reproducibility. Summary reports will be shared with participating clinicians and patients in accessible formats.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eA. Branding and Commercialization:\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe patient-facing mobile application and clinician dashboard will be branded in alignment with institutional and technology partner guidelines. Branding will emphasize usability, trust, and compliance with international standards to support adoption.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eB. Scale-Up Strategy:\u003c/em\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eFollowing successful pilot implementation, the system will be optimized for scalability across diverse hospital ecosystems. This includes:\u003c/p\u003e\n\u003cp\u003e1)Modular architecture for easy integration with existing EHR systems.\u003c/p\u003e\n\u003cp\u003e2)Cloud-based deployment for multi-site expansion.\u003c/p\u003e\n\u003cp\u003e3)Licensing models and premium service options for sustainability.\u003c/p\u003e\n\u003cp\u003e4)Engagement with health authorities and technology partners for policy alignment and funding opportunities.\u003c/p\u003e"},{"header":"IX. LIMITATIONS AND FUTURE SCOPE","content":"\u003cp\u003eThis protocol has several limitations that warrant consideration. First, it is designed for a single-site implementation, which may restrict generalizability across diverse hospital ecosystems with varying infrastructure, workflows, and governance practices. Multi-site trials will be essential to validate scalability and adaptability in different contexts.\u003c/p\u003e\n\u003cp\u003eSecond, the sample size of approximately 200 patients, while appropriate for a Hybrid Type 2 feasibility study, limits statistical power for subgroup analyses and long-term outcome evaluation. Future studies should incorporate larger cohorts to strengthen inferential validity.\u003c/p\u003e\n\u003cp\u003eThird, reliance on hospital EHR data may introduce variability in data quality and completeness due to differences in documentation practices. Although the mobile application mitigates this by capturing real-time patient-reported data, historical inconsistencies in EHR records could still influence predictive accuracy. Advanced data harmonization techniques and integration with IoT-enabled devices may further reduce this risk.\u003c/p\u003e\n\u003cp\u003eFourth, the AI models employed in this protocol are trained on site-specific datasets, which may limit external validity. Incorporating federated learning or multi-institutional datasets in future iterations could enhance model robustness and fairness across diverse populations.\u003c/p\u003e\n\u003cp\u003eLooking ahead, future research should explore multi-site deployments, integration with wearable IoT sensors for richer data streams, and advanced explainability techniques to improve clinician trust and decision-making. Additionally, longitudinal studies assessing cost-effectiveness, policy implications, and patient-reported outcomes will be critical for large-scale adoption and alignment with global digital health strategies.\u003c/p\u003e\n\u003cp\u003eThese mitigation strategies and future directions underscore the protocol’s adaptability and its potential to evolve into a scalable, multi-site solution for AI-driven patient monitoring.\u003c/p\u003e"},{"header":"X. ESTIMATED BUDGET","content":"\u003cp\u003eEstimated budget details are provided in Supplementary File 2 to maintain clarity and conciseness in the main text.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cem\u003eAcknowledgments\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eI acknowledge God for inspiration throughout this work.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eConflict of Interest:\u003c/em\u003e The author declares no conflicts of interest related to this study.\u003cbr\u003e\u003cem\u003eFunding:\u003c/em\u003e No external funding has been secured for this research yet.\u003cbr\u003e\u003cem\u003eData Availability:\u003c/em\u003e This study is conceptual and does not involve primary data; therefore, no datasets were generated or analyzed.\u003cbr\u003e\u003cem\u003eEthical Approval:\u003c/em\u003e Not applicable as this study did not involve human participants or patient data.\u003cbr\u003e\u003cem\u003eConsent for Publication:\u003c/em\u003e Not applicable as this study is a single-author work.\u003cbr\u003e\u003cem\u003ePlagiarism and Originality Statement:\u003c/em\u003e The manuscript does not contain any material that constitutes plagiarism. AI tools were used only for minor language refinement (e.g., correcting tenses) after the paper was written, without altering originality or intellectual content.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eIlesanmi D (2025) AI-integrated patient monitoring and diagnostic model for smart hospital ecosystems. J Healthc Inf Res under Rev. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.17605/OSF.IO/UAQWG\u003c/span\u003e\u003cspan address=\"10.17605/OSF.IO/UAQWG\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKotula CA, Martin J, Carey KA, Edelson DP, Dligach D, Mayampurath A, Afshar M, Churpek MM (2025) Comparison of multimodal deep learning approaches for predicting clinical deterioration in ward patients: Observational cohort study. J Med Internet Res 27:e75340. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.2196/75340\u003c/span\u003e\u003cspan address=\"10.2196/75340\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBaig MM et al (2024) Personalized mHealth interventions using AI: A systematic review. Appl Sci 14(23):10899. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3390/app142310899\u003c/span\u003e\u003cspan address=\"10.3390/app142310899\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGhosh R et al (2025) Ethical and governance frameworks for AI in healthcare: A systematic review. AI Soc. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1007/s00146-025-02312-y\u003c/span\u003e\u003cspan address=\"10.1007/s00146-025-02312-y\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eYing K, Whitehead AL, Julious SA (2025) Determining sample size for pilot trials: A tutorial. BMJ Open 15(3):e078123. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1136/bmjopen-2025-078123\u003c/span\u003e\u003cspan address=\"10.1136/bmjopen-2025-078123\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMontgomery AA, Peters TJ, Little P (2025) Design, analysis and presentation of pilot studies: Recommendations for good practice. J Clin Epidemiol 68(2):139\u0026ndash;147. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.jclinepi.2025.01.001\u003c/span\u003e\u003cspan address=\"10.1016/j.jclinepi.2025.01.001\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLakens D (2022) Sample size justification. Collabra: Psychol 8(1):33267. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1525/collabra.33267\u003c/span\u003e\u003cspan address=\"10.1525/collabra.33267\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Artificial Intelligence, Patient Monitoring, Predictive Analytics, Smart Hospitals, Digital Health, Interoperability, AI Governance","lastPublishedDoi":"10.21203/rs.3.rs-8565588/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8565588/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eHospitals face mounting challenges in delivering proactive, patient-centered care amid resource constraints and rising clinical complexity. Conventional monitoring systems remain reactive and fragmented, leading to delayed interventions and increased adverse events. This paper presents a protocol for implementing an AI-integrated patient monitoring and diagnostic model designed for smart hospital ecosystems. The proposed architecture combines a clinician dashboard, patient-facing mobile application, and a cloud-based AI analytics core within an ethical governance framework. Using a Hybrid Type 2 implementation design, the system aims to unify real-time predictive monitoring, secure communication, and interoperability through HL7 FHIR standards. Anticipated outcomes include accelerated detection of clinical deterioration, reduced adverse event rates, enhanced patient engagement, and improved workflow efficiency. Beyond clinical benefits, the model offers scalable commercialization potential through modular architecture and cloud deployment, aligning with global digital health priorities and WHO strategies. This protocol lays the foundation for transforming hospital operations into intelligent, patient-centric ecosystems while ensuring compliance with HIPAA/GDPR and AI governance standards.\u003c/p\u003e","manuscriptTitle":"Protocol for Implementation of an AI-Integrated Patient Monitoring and Diagnostic Model in Smart Hospital Ecosystems: A Hybrid Type 2 Study","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-01-13 10:28:21","doi":"10.21203/rs.3.rs-8565588/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"ae160dd0-d22a-47a6-ab47-519dcc40ce35","owner":[],"postedDate":"January 13th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":60911965,"name":"Artificial Intelligence and Machine Learning"},{"id":60911966,"name":"Medical Informatics"},{"id":60911967,"name":"Information Retrieval and Management"}],"tags":[],"updatedAt":"2026-01-13T10:28:21+00:00","versionOfRecord":[],"versionCreatedAt":"2026-01-13 10:28:21","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8565588","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8565588","identity":"rs-8565588","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}